Abbott Laboratories (ABT) Gains from Investment Securities (2016)
Abbott Laboratories' (ABT) quarterly Gains from Investment Securities came in at -$1.0 million in Q4 2016, down 125.0% quarter-over-quarter from $4.0 million in Q3 2016.
Powered by 
Analysis
Abbott Laboratories (ABT) Gains from Investment Securities (2016) Analysis & Trends
Abbott Laboratories has disclosed Gains from Investment Securities across 1 years of filings, most recently posting -$1.0 million for Q4 2016.
- In Q4 2016, Gains from Investment Securities changed N/A year-over-year to -$1.0 million; the TTM figure through Dec 2016 stood at $480.0 million (changed N/A YoY), while the FY2016 annual figure was $480.0 million, changed N/A from the prior year.
- Gains from Investment Securities came in at -$1.0 million for Q4 2016 at Abbott Laboratories, down from $4.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $477.0 million in Q1 2016 to a low of -$1.0 million in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | -1.00 Mn |
| Sep 30, 2016 | 4.00 Mn |
| Mar 31, 2016 | 477.00 Mn |